hydrazine has been researched along with B16 Melanoma in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (13.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Christgen, S; Kanneganti, TD; Karki, R; Lee, S; Malireddi, RKS; Neale, G; Nguyen, LN; Samir, P; Sharma, BR; Sundaram, B; Vogel, P; Wang, Y; Zheng, M | 1 |
| Dash, A; Kumar, C; Sarma, HD; Satpati, D; Sharma, R; Vats, K | 1 |
| Baker, DL; Bittman, R; Fells, JI; Fujiwara, Y; Kirby, RJ; Lee, SC; Lim, KG; Liu, J; Miller, DD; Nelson, S; Norman, DD; Papoian, R; Parrill, AL; Patil, R; Seibel, W; Tigyi, G; Tsukahara, R | 1 |
| Cichoń, T; Frąckowiak-Wojtasek, B; Gąsowska-Bajger, B; Logghe, M; Mazurek, M; Raniszewska, A; Smolarczyk, R; Szala, S; Wojtasek, H | 1 |
| Cabral, P; Fernandez, M; Gallazzi, F; Gambini, JP; Garcia, MF; Moreno, M; Porcal, W; Quinn, TP; Zhang, X | 1 |
| Azevedo, RA; Barbuto, JA; de Sá Junior, PL; Farias, CF; Ferreira, AC; Ferreira, AK; Figueiredo, CR; Jorge, SD; Kruyt, FA; Palace-Berl, F; Pasqualoto, KF; Rodrigues, CP; Salomón, MA; Tavares, LC; Turra, KM | 1 |
| Burd, CE; Crochiere, M; Elloul, S; Elnaggar, O; Farren, MR; Hennessey, RC; Kashyap, T; Kendra, K; Klebanov, B; Landesman, Y; Lesinski, GB; Shakya, R; Young, G | 1 |
| Boustie, J; Chollet-Krugler, M; Devehat, FL; Roullier, C; Weghe, Pv | 1 |
| Drewa, G; Drewa, T; Woźniak, A; Woźniak, B | 1 |
| King, I; Li, Z; Liu, L; Song, BL; Zheng, LM | 1 |
| Divo, AA; Loomis, RH; Penketh, PG; Rose, WC; Sartorelli, AC; Shyam, K | 1 |
| Chen, Y; Honn, KV; Lamberti, M; Li, L; Nie, D; Szekeres, K; Tang, K; Zacharek, A | 1 |
| Finch, RA; Penketh, PG; Sartorelli, AC; Shyam, K | 1 |
| Bergol'ts, VV; Gorneva, GA; Mladenova, IP; Nikolaeva, TG; Smirnova, ZS | 1 |
| Cosby, LA; Furubayashi, R; Hrubiec, RT; Sartorelli, AC; Shyam, K | 1 |
15 other study(ies) available for hydrazine and B16 Melanoma
| Article | Year |
|---|---|
ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis.
Topics: Adenosine Deaminase; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Death; Cell Transformation, Neoplastic; Colorectal Neoplasms; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Hydrazines; Interferon-gamma; Male; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Knockout; Necroptosis; Pyroptosis; Receptor-Interacting Protein Serine-Threonine Kinases; RNA-Binding Proteins; Signal Transduction; Skin Neoplasms; Triazoles | 2021 |
Topics: Animals; Chlorambucil; Hydrazines; Isotope Labeling; Melanoma, Experimental; Mice; Molecular Targeted Therapy; Nicotinic Acids; Oligopeptides; Technetium; Tissue Distribution | 2017 |
Hits of a high-throughput screen identify the hydrophobic pocket of autotaxin/lysophospholipase D as an inhibitory surface.
Topics: Animals; Antineoplastic Agents; Benzamides; Benzeneacetamides; Cell Line, Tumor; Drug Screening Assays, Antitumor; High-Throughput Screening Assays; Humans; Hydrazines; Hydrophobic and Hydrophilic Interactions; Indoles; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Mutation; Neoplasm Invasiveness; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Structure-Activity Relationship; Sulfonamides; Tetrazoles | 2013 |
Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker.
Topics: Animals; Cell Line, Tumor; Cyclization; Hydrazines; Mechlorethamine; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Prodrugs | 2014 |
Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
Topics: alpha-MSH; Animals; Chelating Agents; Diagnostic Imaging; Edetic Acid; Glycine; Hydrazines; Ligands; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nicotinic Acids; Organotechnetium Compounds; Peptides; Protein Binding; Radiopharmaceuticals; Tissue Distribution | 2015 |
BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity.
Topics: Animals; Apoptosis; Benzoxazoles; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Flow Cytometry; Hydrazines; Melanoma, Experimental; Mice; Microscopy, Fluorescence; Molecular Docking Simulation; Oxadiazoles; Proto-Oncogene Proteins B-raf | 2016 |
The Exportin-1 Inhibitor Selinexor Exerts Superior Antitumor Activity when Combined with T-Cell Checkpoint Inhibitors.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; B7-H1 Antigen; Cell Line, Tumor; CTLA-4 Antigen; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Exportin 1 Protein; Humans; Hydrazines; Immunomodulation; Karyopherins; Melanoma, Experimental; Mice; Neoplasms; Receptors, Cytoplasmic and Nuclear; T-Lymphocytes; Triazoles | 2017 |
A novel aryl-hydrazide from the marine lichen Lichina pygmaea: isolation, synthesis of derivatives, and cytotoxicity assays.
Topics: Animals; Benzyl Compounds; Cell Line, Tumor; Glutamic Acid; Humans; Hydrazines; Isomerism; Lichens; Magnetic Resonance Spectroscopy; Melanoma, Experimental; Mice; Molecular Conformation; Phenylhydrazines | 2010 |
Lipid peroxidation and antioxidant capacity in selected tissues of healthy black C57BL/6J mice and B16 melanoma-bearing mice.
Topics: Animals; Antioxidants; Biphenyl Compounds; Brain; Hydrazines; Lipid Peroxidation; Liver; Lung; Male; Melanins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Oxidative Stress; Picrates; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tumor Cells, Cultured | 2003 |
Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Hydrazines; Injections, Intraperitoneal; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Sulfonamides; Survival Analysis; Time Factors; Tumor Burden; Vidarabine; Weight Loss; Xenograft Model Antitumor Assays | 2007 |
Synthesis and evaluation of 1-acyl-1,2-bis(methylsulfonyl)-2-(2- chloroethyl)hydrazines as antineoplastic agents.
Topics: Acylation; Alkylation; Animals; Antineoplastic Agents; Drug Stability; Female; Glutathione; Hydrazines; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Leukemia L1210; Leukemia P388; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Transplantation; Sarcoma, Experimental; Structure-Activity Relationship; Sulfonamides | 1993 |
Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Chemotaxis; Dinoprost; Dinoprostone; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Fatty Acids, Unsaturated; Fibroblast Growth Factor 2; Humans; Hydrazines; Lung Neoplasms; Lymphokines; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Rats; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2000 |
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M): a novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity.
Topics: Animals; Antineoplastic Agents; Carmustine; Drug Screening Assays, Antitumor; Female; Humans; Hydrazines; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Nitroso Compounds; Prodrugs; Xenograft Model Antitumor Assays | 2001 |
[The action of amino acid di[2-haloethyl]hydrazides on DNA synthesis in normal and tumor cells and on the cell cycle kinetics in mice with melanoma B-16].
Topics: Alkylating Agents; Amino Acids; Animals; Antineoplastic Agents; Cell Cycle; DNA; DNA, Neoplasm; Drug Evaluation, Preclinical; Hydrazines; Melanoma, Experimental; Melphalan; Mice; Neoplasm Transplantation; Time Factors | 1989 |
Synthesis and evaluation of 2-substituted 1-methyl-1-(4-tolylsulfonyl)hydrazines as antineoplastic agents.
Topics: Animals; Antineoplastic Agents; Cell Survival; Drug Evaluation, Preclinical; Hydrazines; Indicators and Reagents; Leukemia L1210; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Structure-Activity Relationship | 1986 |